<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01097564</url>
  </required_header>
  <id_info>
    <org_study_id>P081214</org_study_id>
    <secondary_id>2009-A01163-54</secondary_id>
    <nct_id>NCT01097564</nct_id>
  </id_info>
  <brief_title>COL4A1 Gene Related Cerebra-retinal Angiopathy</brief_title>
  <acronym>COL4A1</acronym>
  <official_title>COL4A1 Gene Related Cerebra-retinal Angiopathy : Clinical Spectrum From Children to Adult, Mutational Spectrum and Application to Routine Management of Affected Patients : a Prospective Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - H么pitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Assistance Publique - H么pitaux de Paris</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This prospective multicenter cohort study aims to define the clinical, radiological and
      mutational spectrum of the disease related to COL4A1 gene.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      150 index patients (children or young adult) will be prospectively recruited over three years
      according to eligibility criteria. Relatives will be also recruited.

      Clinical, brain MRI-MRA and genetic testing (COL4A1 mutation screening) will be conducted for
      each included patient or asymptomatic relatives. 13 French investigating centres will be
      participating to the study.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>February 2010</start_date>
  <completion_date type="Actual">March 2015</completion_date>
  <primary_completion_date type="Actual">March 2015</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Implication of COL4A1 gene (and other related genes) in intracranial haemorrhages of unknown etiology in children and young adults and in brain diffuse small vessel diseases of unknown etiology in young adults.</measure>
    <time_frame>at 36 months</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>To define the whole clinical, radiological and mutational spectrum of COL4A1 gene.</measure>
    <time_frame>at 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>To define any genotype-phenotype correlation in COL4A1 gene disease.</measure>
    <time_frame>at 36 months</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Application of the results in daily clinical practice</measure>
    <time_frame>at 36 months</time_frame>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">132</enrollment>
  <condition>Cerebra-retinal Angiopathy</condition>
  <arm_group>
    <arm_group_label>COL4A1 genetic testing</arm_group_label>
    <description>COL4A1 genetic testing</description>
  </arm_group>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>COL4A1 genetic testing</intervention_name>
    <description>genetic testing</description>
    <arm_group_label>COL4A1 genetic testing</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        -  patients children

          -  patients young adult

          -  family adult symptomatic

          -  family adult asymptomatic
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Inclusion criteria for the index patient :

          -  Children and young adult (&lt; 65 years)

          -  Intracranial hemorrhage of unknown etiology

          -  leukoencephalopathy

          -  Any associated signs (including retinal arteriolar tortuosity, intracranial aneurysm,
             porencephaly, Infantile Cerebral Palsy, juvenile cataract)

        Exclusion criteria:

        (for the index patient)

          -  Hypertension

          -  Diabetes

          -  Other (than COL4A1) genetic small vessel diseases of the brain
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Hugues CHABRIAT, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - H么pitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>H么pital LARIBOISIERE Neurology Department</name>
      <address>
        <city>Paris</city>
        <zip>75010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>January 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 19, 2010</study_first_submitted>
  <study_first_submitted_qc>March 31, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 1, 2010</study_first_posted>
  <last_update_submitted>January 14, 2016</last_update_submitted>
  <last_update_submitted_qc>January 14, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">January 15, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Genetic</keyword>
  <keyword>Cerebral angiopathy</keyword>
  <keyword>Retinal angiopathy</keyword>
  <keyword>COL4A1 gene</keyword>
  <keyword>Infantile Cerebral Palsy</keyword>
  <keyword>Congenital porencephaly</keyword>
  <keyword>Congenital cataract</keyword>
  <keyword>Leukoencephalopathy</keyword>
  <keyword>COL4A1 gene related cerebra-retinal angiopathy</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

